Regulated intramembrane proteolysis (RIP) is a fundamentally conserved mechanism involving sequential cleavage by a membrane-bound Site-1 protease (S1P) and a transmembrane Site-2 protease (S2P). In the opportunistic pathogen Pseudomonas aeruginosa, the alternate sigma factor σ22 activates alginate production and in turn is regulated by the MucABCD system. The anti-sigma factor MucA, which inhibits σ22, is sequentially cleaved via RIP by AlgW (S1P) and MucP (S2P) respectively. In this study, we report high-resolution crystal structures of the MucP PDZ1 and PDZ2 domains. Structural and binding analysis confirms that MucP PDZ2 recognizes the carboxy-terminal Ala136 residue of MucA following Site-1 cleavage by AlgW, while the peptide binding groove of PDZ1 is obstructed by a short α-helix. A structure of MucP PDZ2 with bound MucA peptide shows how PDZ2 binds the newly exposed carboxyl terminus of MucA following AlgW cleavage. The ability of a ΔmucP strain of P. aeruginosa to form biofilms was reduced to a similar extent as a ΔalgW strain. This work paves the way for further studies of MucP and other PDZ-containing S2Ps in regulated intramembrane proteolysis.
Isolated enzymes serve as advantageous platforms for the fabrication of nanomaterials. The objective of this study was to fabricate silver nanoparticles (AgNPs) incorporated with Trametes versicolor laccase and evaluate their diverse biological properties. The AgNPs fabricated through laccase-mediated methods were characterized using various characterization techniques including UV-visible (UV-vis) spectroscopy, Energy-dispersive X-ray (EDX) spectroscopy, Dynamic light scattering (DLS) spectroscopy, Fourier transform infrared (FT-IR) spectroscopy, and Field emission scanning electron microscopy (FE-SEM). The results showed that the laccase-incorporated AgNPs were spherical in shape with a Z-average diameter of 19.40 nm and a zeta potential of -19.2 mV. The AgNPs exhibited significant dose-dependent in vitro α-amylase, urease, and DPPH free radical inhibitory activities, with maximum inhibitions of 83.49 ± 1.06 %, 68.95 ± 3.60 %, and 67.36 ± 3.40 %, respectively, at a concentration of 1000 μg mL-1. Furthermore, the intrinsic pathway-mediated anticoagulant activity of the fabricated AgNPs was confirmed through the activated partial thromboplastin time (aPTT) assay, which serves as a global coagulation assay. Additionally, the laccase-incorporated AgNPs demonstrated antibacterial properties against both standard gram-positive strains of Staphylococcus epidermidis and Streptococcus mutans, with minimum inhibitory concentration (MIC) values of 2 and 4 μg mL-1, and minimum bactericidal concentration (MBC) values of 16 and 16 μg mL-1, respectively. The dose-dependent antibacterial performance of the AgNPs against both bacterial populations was also confirmed through flow cytometry. Moreover, the AgNPs exhibited 61.53 ± 3.17 % and 63.03 ± 1.44 % biofilm degradation against S. epidermidis and S. mutans, respectively, at the maximum tested concentration (20∗MIC).